Literature DB >> 12726724

Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope.

Jean-Rémy Sadeyen1, Sylvie Tourne, Marina Shkreli, Pierre-Yves Sizaret, Pierre Coursaget.   

Abstract

The aims of this study were to generate chimeric human papillomavirus (HPV)-16 L1 virus-like particles (VLPs) in order to identify immunogenic domains and conformational neutralizing epitopes, and to characterize the regions where a foreign epitope could be introduced. We hypothesized that these regions could be on L1 protein loops since they are exposed on the surface of VLPs. The aims of this study were achieved by mutating HPV-16 L1 proteins. Six amino acids encoding for the epitope 78-83 (DPASRE) of the hepatitis B core (HBc) antigen were introduced within the different loops of the L1 protein at positions 56/57, 140/141, 179/180, 266/267, 283/284 or 352/353. All these chimeric L1 proteins were capable of self-assembly into VLPs. The antigenicity and immunogenicity of some of these VLPs were reduced compared to the levels observed with wild-type VLPs. All were nevertheless able to induce neutralizing antibodies. VLPs with insertion at position 266/267 induced lower levels of neutralizing antibodies, suggesting the involvement of residues situated on FG loop in L1 neutralizing epitopes. All the chimeric L1 proteins except the one with insertion at position 56/57 were also able to induce anti-HBc antibodies, thus suggesting exposure of the HBc epitope on the VLP surface. Taken together, our findings indicate the possibility of designing HPV-derived vectors that are less immunogenic and suggest positions for insertion of defined immune epitopes or cell ligands into L1 protein to be exposed on the surface of VLPs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726724     DOI: 10.1016/s0042-6822(02)00134-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

Review 1.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Combinatorial approach to hepadnavirus-like particle vaccine design.

Authors:  Jean-Noel Billaud; Darrell Peterson; Margaret Barr; Antony Chen; Matti Sallberg; Fermin Garduno; Phillip Goldstein; Wendy McDowell; Janice Hughes; Joyce Jones; David Milich
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.

Authors:  Timothy D Culp; Christin M Spatz; Cynthia A Reed; Neil D Christensen
Journal:  Virology       Date:  2007-01-12       Impact factor: 3.616

4.  Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications.

Authors:  Maxime J J Fleury; Antoine Touzé; Marie-Christine Maurel; Thierry Moreau; Pierre Coursaget
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

5.  Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.

Authors:  Maxime J J Fleury; Antoine Touzé; Pierre Coursaget
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

6.  Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera.

Authors:  Joseph J Carter; Greg C Wipf; Margaret M Madeleine; Stephen M Schwartz; Laura A Koutsky; Denise A Galloway
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction.

Authors:  Zhihai Li; Xiaodong Yan; Hai Yu; Daning Wang; Shuo Song; Yunbing Li; Maozhou He; Qiyang Hong; Qingbing Zheng; Qinjian Zhao; Ying Gu; Jun Zhang; Mandy E W Janssen; Giovanni Cardone; Norman H Olson; Timothy S Baker; Shaowei Li; Ningshao Xia
Journal:  Structure       Date:  2016-06-07       Impact factor: 5.006

8.  SVEngine: an efficient and versatile simulator of genome structural variations with features of cancer clonal evolution.

Authors:  Li Charlie Xia; Dongmei Ai; Hojoon Lee; Noemi Andor; Chao Li; Nancy R Zhang; Hanlee P Ji
Journal:  Gigascience       Date:  2018-07-01       Impact factor: 6.524

9.  Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteins.

Authors:  Lori W McGinnes; Trudy G Morrison
Journal:  Curr Protoc Microbiol       Date:  2013-10-02

10.  Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.

Authors:  Slavica Matić; Riccardo Rinaldi; Vera Masenga; Emanuela Noris
Journal:  BMC Biotechnol       Date:  2011-11-15       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.